Muplestim

DB12431InvestigationalProtein Based Therapies

Muplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in...

Mechanism: Pharmacologically active on Interleukin-3 receptor subunit alpha
Curator reviewed
Also known as: Human interleukin-3 (nonglycosylated) · IL-3 (NON-GLYCOSYLATED) · Interleukin 3 · Interleukin 3 (human) · Interleukin-3
Code names: SDZ-ILE-964

Resolves to

Compound

UNIIA802907MI4CAS148641-02-5

Clinical / RWD

RxNorm1311225

Targets

P26951IL3RA

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Drug interactionsStructured to mechanism, not free text

9Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Muplestim, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account